Cleared Traditional

K132524 - CT TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PLANNING APPLICATION

K132524 is an FDA 510(k) clearance for CT TRANSCATHETER AORTIC VALVE IMPLANTAT..., manufactured by Philips Medical Systems. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 305-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
305d
Days
Class 2
Risk

K132524 is an FDA 510(k) clearance for the CT TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PLANNING APPLICATION. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Philips Medical Systems (Cleveland, US). The FDA issued a Cleared decision on June 13, 2014 after a review of 305 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems devices

FDA 510(k) Submission Details - K132524

510(k) Number K132524 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 2013
Decision Date June 13, 2014
Days to Decision 305 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
198d slower than avg
Panel avg: 107d · This submission: 305d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 732
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K132524.
SYNGO, CT DUAL ENERGY
K133648 · Siemens Medical Solutions USA, Inc. · Jul 2014
PARI-PATH SURGICAL NAVIGATION SYSTEM
K133901 · Paritic, Inc. · Jun 2014
ADMIRE
K133646 · Siemens Medical Systems, Inc. · Jun 2014
MAXIO
K132108 · Perfint Healthcare Pvt, Ltd. · May 2014
SOMATOM PERSPECTIVE
K133590 · Siemens Medical Solutions USA, Inc. · Apr 2014
HEPATIC VCAR
K133649 · GE Medical Systems SCS · Apr 2014